Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
about
Li-fraumeni syndromeMap making in the 21st century: charting breast cancer susceptibility pathways in rodent models.Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome.The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammationPrognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.Role of an MDM4 polymorphism in the early age of onset of nasopharyngeal carcinomaIgf2 pathway dependency of the Trp53 developmental and tumour phenotypes.Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortiumMolecular epidemiology of female lung cancerLi-Fraumeni syndrome: cancer risk assessment and clinical management.Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome.Inherited TP53 Mutations and the Li-Fraumeni Syndrome.Polymorphisms in TP53 and MDM2 contribute to higher risk of colorectal cancer in Chinese population: a hospital-based, case-control study.ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.p53 Arg72Pro and MDM2 309 SNPs in hereditary retinoblastoma
P2860
Q22241780-CDE50D78-BD36-4ECA-8FC3-AF462F4C9A52Q33908246-5E5DFFD0-33E9-4680-984B-502540049A13Q34324382-A58D7967-3363-43DF-838D-6711A2E2BCECQ34742708-71CBCB78-7C6C-4884-B3D5-A4C22D16F961Q35169579-1C9D9720-4F1B-46F3-AAEE-6A3F2381CC87Q36075889-6C0AB1D3-D3DF-4DD4-85CD-3E40EFD94B0FQ36386448-D636A53F-B91C-4030-B179-D23132F68AC2Q36672536-A8230EE2-7EC2-45CA-A5B1-B0C388B893A3Q37132684-D3ED44AF-BF8B-4568-AAF0-4BA29A943527Q38197030-E4591A91-8986-4255-88E6-959F8291BCF3Q38853700-BC627D3D-89FD-4206-A93C-9BDA63F157EFQ39167055-07CA860F-33F9-4425-8ADC-322449A22958Q53160111-E26AD579-ADE4-4468-A6AB-D2EEA2936998Q53224664-41AFF843-7E81-4BB3-B562-7BE75AD8B7E3Q53727895-CFB6D0AB-A5D4-4D38-8ED5-3670D5AA0098Q59330949-E1869479-5AC0-4117-BDD2-9077CEAEF7FC
P2860
Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effects of MDM2, MDM4 and TP53 ...... rs of TP53 germline mutations.
@ast
Effects of MDM2, MDM4 and TP53 ...... rs of TP53 germline mutations.
@en
type
label
Effects of MDM2, MDM4 and TP53 ...... rs of TP53 germline mutations.
@ast
Effects of MDM2, MDM4 and TP53 ...... rs of TP53 germline mutations.
@en
prefLabel
Effects of MDM2, MDM4 and TP53 ...... rs of TP53 germline mutations.
@ast
Effects of MDM2, MDM4 and TP53 ...... rs of TP53 germline mutations.
@en
P2093
P2860
P1433
P1476
Effects of MDM2, MDM4 and TP53 ...... rs of TP53 germline mutations.
@en
P2093
Baili Zhang
Charmaine D Wilson
Guillermina Lozano
Linda L Bachinski
Louise C Strong
Ralf Krahe
Sean M Post
Younghun Han
P2860
P304
P356
10.1371/JOURNAL.PONE.0010813
P407
P577
2010-05-26T00:00:00Z